Doo-Hong Park

Title: Innovations and Contributions of Inventor Doo-Hong Park

Introduction

Doo-Hong Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors and anticancer agents. With a total of four patents to his name, his work has had a substantial impact on medical and scientific research.

Latest Patents

One of his latest patents is an expression vector for animal cells. This invention relates to an expression vector, specifically the pMS vector, pSG vector, and pMSG vector, which includes the human β-globin 5' MAR complementary sequence and/or the transcription termination site of the gastrin gene. The expression system utilizing this vector can successfully produce recombinant proteins in various animal cells, leading to proteins with unique structures and functions. Another significant patent is for an anticancer agent, which discloses a method of reducing tumor growth. This method involves contacting the tumor with a composition comprising LK8 or LK68 protein, or a functionally equivalent amino acid variant, along with a pharmaceutically acceptable carrier.

Career Highlights

Doo-Hong Park has worked with prominent organizations such as Mogam Biotechnology Research Institute and Neurotech Pharmaceuticals. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in biotechnology.

Collaborations

He has collaborated with notable colleagues, including Soo-Il Chung and Yeup Yoon, further enhancing the scope and impact of his work.

Conclusion

Doo-Hong Park's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and therapeutic applications.